4011-17: An Introduction to Medication Assisted Treatments for Opiate Use Disorders

Drug overdoses are a leading cause of accidental death . CARA has expanded the role for Advanced Practice Nurses in treating opiate use disorders with Medication Assisted Treatments (MAT) such as buprenorphine and forms of naltrexone.  This session is an introduction to MAT.

Presenter: Mary Weber, PhD, PMHNP-BC, FAANP, FAAN

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.

Session Length:  46 minutes

Target Audience:  APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

1. Describe non-pharmacological strategies for use in chronic pain and opioid use disorder.
2. Discuss the role of the RN and APN in the identification and treatment of opioid use disorders since passage of CARA.
3. Identify how to safely use buprenorphine and naltrexone in the treatment of opioid use disorders and how to get additional training.

Keywords: Medication Assisted Treatment, Buprenorphine, Opioids, Overdose

Continuing Nursing Education:
0.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 31st Annual Conference
Phoenix, Arizona
Saturday, October 21, 2017
10:15am - 11:00am

The contact hours for this session expire:  January 1, 2021